CureVac NV (NAS:CVAC)
$ 4.32 0.45 (11.57%) Market Cap: 969.00 Mil Enterprise Value: 587.35 Mil PE Ratio: 0 PB Ratio: 2.00 GF Score: 69/100

CureVac NV Annual Shareholders Meeting Transcript

Jun 22, 2022 / 12:00PM GMT
Release Date Price: $14.31 (+0.92%)
Jean StÃ;phenne

© -

Ladies and gentlemen, welcome to the Annual General Meeting of the Shareholders of CureVac N.V. My name is Jean Stéphenne, Chairman of the Supervisory Board of CureVac N.V. In accordance with our Article of Association, I will share today's meeting. Our General Counsel, Marco Rau will act as secretary of this meeting.

First, allow me to introduce the Managing Director, Supervisory Director, Officer and other representatives of the company present here today: Franz-Werner Haas, our CEO; Pierre Kemula, our CFO; Malte Greune, our Chief Operating Officer and Managing Director nominee; Igor Splawski, our Chief Scientific Officer; Antony Blanc, our Chief Business Officer and Chief Commercial Officer; Craig Tooman, one of our Supervisory Director; and Marco Rau, our General Counsel.

I would like also to welcome the other board members who are our colleagues in the Board, Viola Bronsema, Chris Tanner and Mathias Hothum. Also present are our Dutch Legal Counsel, Paul van der Bijl and Sanne Mesu; [Peter Mau] our auditor; Mr. [Rene Frenz] working with Ernst & Young

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot